However, variance seen in persistence of effects with no predictive factors identified
TUESDAY, Oct. 31, 2023 (HealthDay News) — Classic psychedelics may be effective in reducing symptoms of obsessive-compulsive disorder (OCD), according to a study recently published online in Scientific Reports.
Anne Buot, Ph.D., from Sorbonne Université in Paris, and colleagues conducted an online survey to assess the impact on OCD symptoms in the general population using psychoactive drugs. The analysis included responses from 174 participants.
Responses showed that classic psychedelics were perceived as the only substances effective at reducing OCD symptoms. Symptom reduction was associated with the intensity of acute effects and correlated to the dose in classic psychedelics users. The reported persistence of the therapeutic effect varied from weeks to months, but no factors predicted persistence. The occurrence and frequency of subsequent intakes were limited in this sample and were predicted by the magnitude and persistence of the therapeutic effect, respectively.
“These results should not be generalized to the entire OCD population until the outcome of randomized controlled clinical trials confirms our observations,” the authors write.
Several authors disclosed ties to companies related to psychedelics.
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Study IDs Neurobiological Roots of Sensory Over-Responsivity 
